By Richard Nelson, managing editor, February 01, 2011
In 2005, the American Academy of Dermatology and Society for Investigative Dermatology compiled the Burden of Skin Diseases report, which detailed that burden in terms of prevalence and cost. The report included direct cost data (shown below in green). It also calculated a total cost for each disease, including indirect costs due to lost productivity, defined as days of work lost due to the disease (shown below in burgundy). Finally, it calculated the quality of life cost of each disease (shown below in orange). As the chart below demonstrates, even a disease outside the top 10 in prevalence, like psoriasis, can have such a dramatic impact on the quality of life of those who have it that it rates fifth among skin diseases by that metric.